Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333)


See all MSLN antibodies
Online Inquiry
Tested Data
Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333) in ELISA
Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333) in ELISA
Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333) in WB
Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333) in WB
Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333) in WB
Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333) in WB
Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333) in WB
Mouse Anti-MSLN Recombinant Antibody (CBT3741) (V2LY-0625-LY1333) in WB

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBT3741
Antibody Isotype
IgG1
Application
WB

Basic Information

Immunogen
Purified recombinant fragment of human MSLN (AA: 296-606) expressed in E. Coli.
Host Species
Mouse
Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal Antibody
Application Notes
ApplicationNote
WB1:500-1:2,000
ELISA1:10,000

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
Sodium azide
Concentration
Batch dependent
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Entrez Gene ID
10232
UniProt ID
Q13421
Function
Membrane-anchored forms may play a role in cellular adhesion.

Megakaryocyte-potentiating factor (MPF) potentiates megakaryocyte colony formation in vitro.
Biological Process
Cell adhesion Source: UniProtKB
Cell-matrix adhesion Source: GO_Central
Pancreas development Source: Ensembl
Cellular Location
Plasma membrane
Cell membrane
Golgi apparatus
Megakaryocyte-potentiating factor:
Secreted
Isoform 3:
Secreted
Involvement in disease
Antibodies against MSLN are detected in patients with mesothelioma and ovarian cancer.
PTM
Both MPF and the cleaved form of mesothelin are N-glycosylated.
Proteolytically cleaved by a furin-like convertase to generate megakaryocyte-potentiating factor (MPF), and the cleaved form of mesothelin.
More Infomation

Hagerty, B. L., & Takabe, K. (2023). Biology of Mesothelin and Clinical Implications: A Review of Existing Literature. World Journal of Oncology, 14(5), 340.

Wang, Q., & Gong, R. (2022). Immunotherapy targeting mesothelin in acute myeloid leukemia. Journal of Leukocyte Biology, 112(4), 813-821.

Schoutrop, E., El-Serafi, I., Poiret, T., Zhao, Y., Gultekin, O., He, R., ... & Mattsson, J. (2021). Mesothelin-specific CAR T cells target ovarian cancer. Cancer Research, 81(11), 3022-3035.

Klampatsa, A., Dimou, V., & Albelda, S. M. (2021). Mesothelin-targeted CAR-T cell therapy for solid tumors. Expert opinion on biological therapy, 21(4), 473-486.

Weidemann, S., Gagelmann, P., Gorbokon, N., Lennartz, M., Menz, A., Luebke, A. M., ... & Simon, R. (2021). Mesothelin expression in human tumors: a tissue microarray study on 12,679 tumors. Biomedicines, 9(4), 397.

Kaeding, A. J., Barwe, S. P., Gopalakrishnapillai, A., Ries, R. E., Alonzo, T. A., Gerbing, R. B., ... & Meshinchi, S. (2021). Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia. Blood Advances, 5(9), 2350-2361.

Montemagno, C., Cassim, S., Pouyssegur, J., Broisat, A., & Pagès, G. (2020). From malignant progression to therapeutic targeting: current insights of mesothelin in pancreatic ductal adenocarcinoma. International Journal of Molecular Sciences, 21(11), 4067.

Shen, J., Sun, X., & Zhou, J. (2020). Insights into the role of mesothelin as a diagnostic and therapeutic target in ovarian carcinoma. Frontiers in Oncology, 10, 1263.

Hagemann, U. B., Ellingsen, C., Schuhmacher, J., Kristian, A., Mobergslien, A., Cruciani, V., ... & Cuthbertson, A. S. (2019). Mesothelin-targeted thorium-227 conjugate (MSLN-TTC): preclinical evaluation of a new targeted alpha therapy for mesothelin-positive cancers. Clinical Cancer Research, 25(15), 4723-4734.

Lv, J., & Li, P. (2019). Mesothelin as a biomarker for targeted therapy. Biomarker Research, 7(1), 1-18.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-MSLN Recombinant Antibody (CBT3741)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Request bulk or custom quote
Second antibody and isotype control

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Online Inquiry